SILEXION THERAPEUTICS CORP

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for G1281K122 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Lincoln Alternative Strategies LLC 13G	6.2%	131,250	13G	9/15/2025 Event 9/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Intracoastal Capital LLC 13G	4.99%	209,827	13G	1/21/2025 Event 1/15/2025
Mitchell P. Kopin	4.99%	209,827
Daniel B. Asher	4.99%	209,827
Intracoastal Capital LLC	4.99%	209,827
Lind Global Fund III LP 13G/A	4.96%	212,500	13G/A	5/15/2026 Event 3/31/2026
Lind Global Fund III LP	4.96%	212,500
Lind Global Partners III LLC	4.96%	212,500
Easton Jeff	4.96%	212,500
CVI Investments, Inc. 13G/A	4.9%	456,531	13G/A	5/12/2025 Event 3/31/2025
CVI Investments, Inc.	4.9%	456,531
Heights Capital Management, Inc.	4.9%	456,531
Goldman Sachs Group Inc 13G/A	2.4%	211,945	13G/A	5/13/2025 Event 3/31/2025
The Goldman Sachs Group, Inc.	2.4%	211,945
Goldman Sachs & Co. LLC	2.4%	211,945
Wildcat Capital Management, LLC 13D/A	1.3%	113,428	13D/A	6/26/2025 Event 6/26/2025
Wildcat Capital Management, LLC	1.3%	113,428
Wildcat Partner Holdings, LP	1.3%	113,428
Leonard A. Potter	1.3%	113,428

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q2	7	282 k	$229 k	$0
2025 Q1	6	236 k	$260 k	$0
2024 Q4	4	140 k	$281 k	$0